Anixa Biosciences, Inc. - ANIX
About Gravity Analytica
Recent News
- 04.14.2025 - Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
- 04.09.2025 - Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
- 04.01.2025 - Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th
- 03.25.2025 - Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines
- 03.24.2025 - Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine
- 03.21.2025 - 8-K - Current report
- 03.17.2025 - Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th
- 03.11.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
- 03.10.2025 - Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
- 03.03.2025 - Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th